Weidson
☆    

Brazil,
2018-04-09 22:40
(2205 d 19:25 ago)

Posting: # 18658
Views: 1,729
 

 In vitro Bioequivalence for suspension ophthalmic [Regulatives / Guidelines]

Post reply
Dear All,

Has anyone in this group ever performed an in vitro bioequivalence study with an ophthalmic suspension that was guided by the Guidance on Dexamethasone / tobramycin (reviewed June 2012, June 2013 and June 2016)? If yes, what is the acceptance criterion for bioequivalence? In the draft nothing is mentioned for the range of acceptance of the mortality rate of the microorganisms.

https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm308032.pdf

Thanks vary much.
 
UA Flag
Activity
 Admin contact
22,991 posts in 4,827 threads, 1,648 registered users;
52 visitors (2 registered, 50 guests [including 6 identified bots]).
Forum time: 18:06 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5